OTTAWA – Canada is donating a made-in-Manitoba Ebola vaccine to help respond to the large outbreak of the deadly Ebola virus in West Africa.
The vaccine was developed at the National Microbiology Lab in Winnipeg. It has shown 100 per cent effectiveness at preventing Ebola in non-human primates.
It has never been tested in humans.
Canada owns the intellectual property rights for the vaccine but has licensed the rights to U.S. company BioProtection Systems to develop it for use in humans.
Canada is donating between 800 and 1,000 doses to the World Health Organization. It’s not clear yet how the WHO will use the vaccine.
The vaccine is not the same drug that was used to help two American patients flown back to the United States after treating patients in West Africa.
More than 1,000 people have died from the Ebola outbreak, which is the largest on record.